YORK, England, June 15, 2011 /PRNewswire/ — Intelsius, a global
manufacturer and distributor of environmentally safe,
temperature-controlled and regulatory-compliant packaging
solutions, announced today that it has appointed Dr. F. John Mills,
M.D., Ph.D., to the company’s board of directors as non-executive
chair. Dr. Mills joins Intelsius with more than 25 years of
executive and leadership experience in the pharmaceutical and
biotech industries.
(Logo:
http://photos.prnewswire.com/prnh/20101012/DE80101LOGO)
“I look forward to bringing my experience to Intelsius during
such a time of global growth,” said Dr. Mills. “The company has all
of the components for continued success in the global marketplace
including an industry-experienced management team, strong product
offerings, established partnerships and customer adoption and
endorsement around the world.”
Dr. Mills is currently Chairman of the Board for BioStorage
Technologies, a premier service provider of comprehensive sample
management services for biological samples collected during
clinical research. Mills co-founded the company in 2003 and also
served as CEO before resigning from the position in late 2010. In
2009, Dr. Mills was appointed to the board of directors for
ChanTest Corporation, a leading provider of cardiac safety, ion
channel and GPCR services and products. In addition, Dr. Mills is a
member of the board of directors for Bostech Corporation, a
healthcare interoperability organization; and also serves as a
strategic advisor to Popper and Company, an M&A advisory and
specialty consulting firm.
Prior to founding BioStorage Technologies, Dr. Mills held roles
of increasing responsibility at Covance, where he served as the
Corporate Senior Vice President and President, Clinical Support
Services. In addition to Covance, Dr. Mills has held senior
management positions at Corning and Janssen Pharmaceutical.
“We greatly value Dr. Mills’ industry insight, knowle
‘/>”/>
